Dominick Amato

596 total citations
26 papers, 427 citations indexed

About

Dominick Amato is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Dominick Amato has authored 26 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 9 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Dominick Amato's work include Lysosomal Storage Disorders Research (16 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Dominick Amato is often cited by papers focused on Lysosomal Storage Disorders Research (16 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Glycosylation and Glycoproteins Research (4 papers). Dominick Amato collaborates with scholars based in Canada, United States and United Kingdom. Dominick Amato's co-authors include Siavash Piran, Khalid Hassan, G.T. Nurse, Shih‐Chun Liu, J Palek, David E. Golan, Petr Jarolı́m, Thérèsa L. Coetzer, Sarah Borwein and J. Fernandes and has published in prestigious journals such as New England Journal of Medicine, Blood and Gastroenterology.

In The Last Decade

Dominick Amato

26 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominick Amato Canada 10 200 150 144 53 53 26 427
C. E. Hatton United Kingdom 9 337 1.7× 61 0.4× 157 1.1× 71 1.3× 69 1.3× 11 471
Gabriela Pasqualim Brazil 13 258 1.3× 64 0.4× 155 1.1× 54 1.0× 10 0.2× 31 397
J. Gehler Germany 12 242 1.2× 69 0.5× 176 1.2× 77 1.5× 10 0.2× 30 446
Akiko Nakatomi Japan 9 72 0.4× 47 0.3× 163 1.1× 21 0.4× 13 0.2× 19 337
FA Kuypers United States 6 257 1.3× 32 0.2× 176 1.2× 7 0.1× 96 1.8× 9 455
R Humbel Luxembourg 9 166 0.8× 63 0.4× 143 1.0× 87 1.6× 10 0.2× 27 425
Sabrina Pagliei Italy 8 42 0.2× 45 0.3× 298 2.1× 10 0.2× 26 0.5× 9 533
Michael Beck Germany 7 123 0.6× 181 1.2× 178 1.2× 35 0.7× 17 0.3× 12 363
VK Kalra India 10 125 0.6× 29 0.2× 80 0.6× 7 0.1× 113 2.1× 32 390
Hagit Baris Feldman Israel 11 67 0.3× 33 0.2× 131 0.9× 24 0.5× 16 0.3× 42 366

Countries citing papers authored by Dominick Amato

Since Specialization
Citations

This map shows the geographic impact of Dominick Amato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominick Amato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominick Amato more than expected).

Fields of papers citing papers by Dominick Amato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominick Amato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominick Amato. The network helps show where Dominick Amato may publish in the future.

Co-authorship network of co-authors of Dominick Amato

This figure shows the co-authorship network connecting the top 25 collaborators of Dominick Amato. A scholar is included among the top collaborators of Dominick Amato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominick Amato. Dominick Amato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryan, Emory, Dominick Amato, Jennifer MacKenzie, Ellen Sidransky, & Grisel Lopez. (2020). Parkinsonism in Patients with Neuronopathic (Type 3) Gaucher Disease: A Case Series. Movement Disorders Clinical Practice. 7(7). 834–837. 7 indexed citations
2.
3.
Amato, Dominick, et al.. (2016). Hair repigmentation associated with thalidomide use for the treatment of multiple myeloma. BMJ Case Reports. 2016. bcr2016215521–bcr2016215521. 9 indexed citations
4.
5.
Weinreb, Neal J., David N. Finegold, Eleanor Feingold, et al.. (2015). Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3). Orphanet Journal of Rare Diseases. 10(1). 64–64. 31 indexed citations
6.
Pastores, Gregory M., Мilan Petakov, Pilar Giraldo, et al.. (2014). A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. 53(4). 1 indexed citations
7.
Charrow, Joel, Hiroyuki Ida, Carla E. M. Hollak, et al.. (2014). EDGE: A Phase 3 study evaluating once versus twice daily dosing of eliglustat in patients with Gaucher disease type 1: interim results from the lead-in-period. Molecular Genetics and Metabolism. 111(2). S30–S30. 1 indexed citations
8.
9.
Zimran, Ari, Atul Mehta, Pilar Giraldo, et al.. (2013). Long-term safety and efficacy data of taliglucerase alfa, a Plant cell-expressed recombinant glucocerebrosidase, in the treatment of naïve Gaucher disease patients: 36-Month Results. Molecular Genetics and Metabolism. 108(2). S102–S102. 2 indexed citations
10.
Pastores, Gregory M., Suma P. Shankar, Jeff Szer, et al.. (2013). Plant cell-expressed recombinant glucocerebrosidase: Taliglucerase alfa as therapy for Gaucher disease in adults patients previously treated with imiglucerase: 24-month results. Molecular Genetics and Metabolism. 108(2). S73–S74. 3 indexed citations
11.
Zimran, Ari, René Heitner, Atul Mehta, et al.. (2012). Long Term Safety and Efficacy Data of Taliglucerase Alfa, a Plant Cell Expressed Recombinant Glucocerebrosidase, in Treatment Of Naïve Gaucher Disease Patients. Molecular Genetics and Metabolism. 105(2). S68–S68. 3 indexed citations
12.
Piran, Siavash, et al.. (2008). The Clinical Course of Untreated Gaucher Disease in 22 Patients Over 10 Years: Hematological and Skeletal Manifestations.. Blood. 112(11). 1264–1264. 2 indexed citations
13.
Usenko, Tatiana, D Eskinazi, Paulo N. Correa, et al.. (2007). Overexpression of SOCS-2 and SOCS-3 genes reverses erythroid overgrowth and IGF-I hypersensitivity of primary polycythemia vera (PV) cells. Leukemia & lymphoma. 48(1). 134–146. 10 indexed citations
14.
Wang, Chen & Dominick Amato. (2007). Chronic and severe haemolytic anaemia caused by co‐inheritance of β‐thalassaemia and triplicated α‐globin genes. British Journal of Haematology. 137(6). 489–489. 1 indexed citations
15.
Amato, Dominick, et al.. (2003). Acute Tumor Lysis Syndrome Secondary to Hydroxyurea in Acute Myeloid Leukemia. Annals of Pharmacotherapy. 37(5). 675–678. 8 indexed citations
16.
Oh, Jangsuk, Lingling Ho, Sirpa Ala‐Mello, et al.. (1998). Mutation Analysis of Patients with Hermansky-Pudlak Syndrome: A Frameshift Hot Spot in the HPS Gene and Apparent Locus Heterogeneity. The American Journal of Human Genetics. 62(3). 593–598. 120 indexed citations
17.
Klein, Ami, et al.. (1990). Cortisol catabolism by lymphocytes of patients with chronic lymphocytic leukemia. Biochemistry and Cell Biology. 68(4). 810–813. 3 indexed citations
18.
Liu, Shih‐Chun, J Palek, David E. Golan, et al.. (1990). Molecular Defect of the Band 3 Protein in Southeast Asian Ovalocytosis. New England Journal of Medicine. 323(22). 1530–1538. 96 indexed citations
19.
Fernandes, J. & Dominick Amato. (1986). Reply. Gastroenterology. 90(6). 2042–2042. 1 indexed citations
20.
Fernandes, J., et al.. (1985). Diffuse Lymphomatous Polyposis of the Gastrointestinal Tract. Gastroenterology. 88(5). 1267–1270. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. E. Hatton Breakdown of academic impact, for papers by Gabriela Pasqualim Breakdown of academic impact, for papers by J. Gehler Breakdown of academic impact, for papers by Akiko Nakatomi Breakdown of academic impact, for papers by FA Kuypers Breakdown of academic impact, for papers by R Humbel Breakdown of academic impact, for papers by Sabrina Pagliei Breakdown of academic impact, for papers by Michael Beck Breakdown of academic impact, for papers by VK Kalra Breakdown of academic impact, for papers by Hagit Baris Feldman
Rankless by CCL
2026